Cannabis Sativa, Inc. (CBDS)
- Previous Close
0.0190 - Open
0.0180 - Bid --
- Ask --
- Day's Range
0.0180 - 0.0191 - 52 Week Range
0.0100 - 0.0600 - Volume
60,512 - Avg. Volume
77,483 - Market Cap (intraday)
1.3M - Beta (5Y Monthly) 1.45
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0400 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Cannabis Sativa, Inc., through its subsidiaries, primarily provides telemedicine online referral services for customers desiring medical marijuana cards in the United States. The company offers PrestoDoctor, an online telemedicine platform, which provides access to physicians for getting a medical marijuana recommendation using video conferencing technology. Its products under development include Lozenges for relief from throat irritation; Recover, a deep penetrating healing balm used to relieve pain for sore muscles, joints, arthritic, and back pain; Trauma Cream, a cream for blended infusion of cannabinoids and THC; Face Garden, an antioxidant moisturizing cream for the face; Body Garden, a moisturizing body lotion; and Lip Garden, an emollient balm. The company also offers Wild Earth Naturals and hi branded men's and women's fashion tee shirts and sweatshirts, as well as caps and coffee mugs through Website, wildearthnaturals.com; and holds intellectual property license for manufacture of medical marijuana edibles. It serves cannabidiol and marijuana industries. The company was formerly known as Ultra Sun Corporation and changed its name to Cannabis Sativa, Inc. November 2013. Cannabis Sativa, Inc. is based in Mesquite, Nevada.
6
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: CBDS
Performance Overview: CBDS
Trailing total returns as of 4/23/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: CBDS
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: CBDS
Valuation Measures
Market Cap
1.37M
Enterprise Value
1.57M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.74
Price/Book (mrq)
--
Enterprise Value/Revenue
1.27
Enterprise Value/EBITDA
-1.09
Financial Highlights
Profitability and Income Statement
Profit Margin
-137.68%
Return on Assets (ttm)
-24.31%
Return on Equity (ttm)
-99.85%
Revenue (ttm)
1.24M
Net Income Avi to Common (ttm)
-1.7M
Diluted EPS (ttm)
-0.0400
Balance Sheet and Cash Flow
Total Cash (mrq)
144.91k
Total Debt/Equity (mrq)
33.70%
Levered Free Cash Flow (ttm)
63.12k
Company Insights: CBDS
CBDS does not have Company Insights